Clinical Trials - International

This page contains information about clinical trials that are sponsored by AtriCure, Inc. If you wish to learn more about any of AtriCure’s sponsored clinical trials, please visit the clinicaltrials.gov website to learn more.

CEASE-AF

Device: AtriCure Bipolar System

• Protocol Title: Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation versus Repeated Catheter Ablation in Persistent and Long-standing Persistent Atrial Fibrillation)
• Study Design: Prospective, Randomized (2:1 ratio) multi-center trial
• Objectives: To compare the efficacy and safety of two interventional approaches (hybrid ablation versus standard catheter ablation), in preventing the recurrence of AF in symptomatic, drug refractory patients with persistent or long-standing persistent AF.

ClinicalTrials.gov identifier: NCT02695277

The information contained on this page and/or its links are not intended to promote or otherwise commercialize unapproved devices or unapproved uses of approved AtriCure devices.